[1]Drilon A, Sharma M R, Johnson M L, et al. SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy[J]. Cancer Discovery, 2023.
[2]Asmamaw M D, Shi X J, Zhang L R, et al. A comprehensive review of SHP2 and its role in cancer[J]. Cellular Oncology, 2022, 45(5): 729-753.